$48.7 billion for the National Institutes of Health (NIH), a $400 million increase for the largest source of lupus research funding in the world. The bill also provides a $30 million increase in ...

The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment ...

A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in ...

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment target for people with lupus nephritis (LN, lupus-related kidney disease).

The Lupus Foundation of America (LFA) and Lupus Canada are pleased to announce Mohamed Osman, MD, PhD, Associate Professor of ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), including in people without a diagnosis of lupus nephritis (LN, lupus-related ...

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage BCMAxCD3 bispecific T cell engager.

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

Download Full Size Version Hair care tips to consider with lupus: How to do more with less Keep your hair cut short to prevent breakage from extra weight. Shaped cuts with light layers to give the ...

Mesenchymal stem cells (MSCs) are unique adult stem cells with immunosuppressive properties that also may play a key role in preventing autoimmunity. In a new study, researchers identified metabolic ...

Today, the U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for Gazyva® (Obinutuzumab), for the potential treatment of lupus nephritis ...